Failure to Launch: The Patent Thicket Delay of US Biosimilars

September 23, 2026

CCWC 22nd Annual Career Strategies Conference

Axinn attorneys Leslie Overton, Denise Plunkett, Jackie Lem, Katrina Rouse, and Monica Smith will speak during the Corporate Counsel Women of Color’s Career Strategies Conference, being held September 23–26 in Orlando, FL.

Sponsorship

September 16, 2026

Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop

Axinn partner Kail Jethmalani will speak on a panel during the Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop. The September 17 panel is titled "Competitor Collaborations or Cartels: Revising the Antitrust Framework for an Algorithmic Age."

Sponsorship

Antitrust

September 15, 2026

Women, Influence, & Power in Law Conference 2026

On September 15, Axinn Partner Mary Helen Wimberly will speak on the "Antitrust in Transition: Risks & Opportunities in a Dynamic Market" panel at ALM"s Women, Influence, & Power in Law Conference, being held September 14–16, 2026 in Nashville, TN.

Sponsorship

Antitrust

September 14, 2026

IP Litigation North America Summit 2026

Axinn Partner Matthew Murphy will speak on a panel during the IP Litigation North America Summitt 2026 on September 14.

Sponsorship

Intellectual Property

September 9, 2026

HNBA/VIA Annual Convention 2026

Axinn is pleased to announce its sponsorship of the Hispanic National Bar Association and VIA Fund’s Annual Convention.

Sponsorship

Antitrust

September 9, 2026

The DOJ’s Antitrust Whistleblower Rewards Program

Axinn partner Jimmy Attridge will speak during a Federal Bar Association webinar titled "The DOJ’s Antitrust Whistleblower Rewards Program" on September 9.

Webinar

Antitrust

September 4, 2026

30th Annual IBA Competition Conference

Axinn is proud to sponsor the International Bar Association’s Annual Competition Conference, being held September 4-5 in Florence, Italy.

Speaking Engagement

Antitrust

September 2, 2026

ABA 2026 Antitrust Global Seminar Series

On September 2, Axinn partner Jimmy Attridge will speak on the "Competitor Collaborations, Information Sharing and Algorithms" panel during the American Bar Association's 2026 Antitrust Global Seminar Series, being held in Brussels, Belgium.

Speaking Engagement

Antitrust

August 24, 2026

Do I Really Need To File? HSR Avoidance and the Edwards/Genesis Settlement

For nearly 50 years, the Hart-Scott-Rodino Act has given antitrust enforcers a chance to review deals above a certain value before they can close. What happens when the government concludes a transaction was structured intentionally to slip past that review entirely?

Podcast

Antitrust

August 20, 2026

Axinn Attorneys Earn Top Honors in Best Lawyers 2027

Axinn LLP announced today that nine of its attorneys have been recognized in the 2027 edition of The Best Lawyers in America®, with an additional 18 attorneys named to Best Lawyers: Ones to Watch in America. Partner Matthew S. Murphy was recognized for “Lawyer of the Year” honors in Litigation – Intellectual Property and Litigation – Patent.

News

Antitrust

August 13, 2026

DOJ's Antitrust Division Remains Interested in Your Private Litigation

Axinn partner Mary Helen Wimberly authored the Westlaw Today article "DOJ's Antitrust Division Remains Interested in Your Private Litigation."

Byline Articles

Antitrust

August 12, 2026

Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, on the completed sale of its microbiology business to Astorg, a leading pan-European private equity firm, for approximately $1.075 billion. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing.

Deals & Cases

Antitrust

Failure to Launch: The Patent Thicket Delay of U.S. Biosimilars

Related People

Related Services

Featured Insights

Featured Insights